Altria Group's adjusted earnings per share grew over 7% last quarter, beating expectations and supporting continued dividend increases and share buybacks. Despite top-line stagnation, its resilient business model and strong dividends keep it attractive to investors. The stock trades at a higher valuation than its historical average but remains in line with peers like British American Tobacco and at a discount to Philip Morris. The main risk is slow progress in its smoke-free product segment, with oral tobacco (on!) driving growth amid declining cigarette sales.
Altria Group's stock has gained 24% over the past year, outperforming its benchmark's 19% rise. Despite this, the stock trades at a 14% discount to the sector median on forward price-to-earnings ratio, standing at 13x compared to peers' 15x. It offer...
Altria Group is rated Sell because its stock trades at a 30% premium to its historical price-to-earnings ratio, despite stagnant financial results and uncertain growth prospects in smoke-free products. While its Q1 performance in traditional smokeabl...
The Dividend Harvesting Portfolio surpassed $40,000 in value, achieving a 43.6% return on invested capital by focusing on consistent dividend income growth rather than market timing. Its forward annualized dividend income reached $3,158.42 with a 7.8...
